SMC: Zoledronic acid (Aclasta) not recommended for treatment of osteoporosis in men

This is the advice published by the Scottish Medicines Consortium about the use of zoledronic acid for the treatment of osteoporosis in men. ADVICE: in the absence of a submission from the holder of the marketing authorisation. zoledronic acid 5mg (Aclasta┬«) is not recommended for use within NHSScotland for the treatment of osteoporosis in men […]